Amgen Inc. (AMGN)

NASDAQ: AMGN · IEX Real-Time Price · USD
284.32
-1.98 (-0.69%)
At close: Mar 28, 2024, 4:00 PM
284.58
+0.26 (0.09%)
After-hours: Mar 28, 2024, 5:13 PM EDT

Total Valuation

Amgen has a market cap or net worth of $153.43 billion. The enterprise value is $207.10 billion.

Market Cap 153.43B
Enterprise Value 207.10B

Important Dates

The next estimated earnings date is Thursday, April 25, 2024, after market close.

Earnings Date Apr 25, 2024
Ex-Dividend Date May 16, 2024

Share Statistics

Amgen has 535.92 million shares outstanding. The number of shares has decreased by -0.55% in one year.

Shares Outstanding 535.92M
Shares Change (YoY) -0.55%
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.25%
Owned by Institutions (%) 80.90%
Float 534.35M

Valuation Ratios

The trailing PE ratio is 22.76 and the forward PE ratio is 14.26. Amgen's PEG ratio is 2.56.

PE Ratio 22.76
Forward PE 14.26
PS Ratio 5.44
Forward PS 4.54
PB Ratio 24.62
P/FCF Ratio 20.85
PEG Ratio 2.56
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.99, with an EV/FCF ratio of 28.14.

EV / Earnings 30.83
EV / Sales 7.35
EV / EBITDA 13.99
EV / EBIT 19.30
EV / FCF 28.14

Financial Position

The company has a current ratio of 1.65, with a Debt / Equity ratio of 10.37.

Current Ratio 1.65
Quick Ratio 0.99
Debt / Equity 10.37
Debt / EBITDA 4.37
Debt / FCF 8.78
Interest Coverage 3.73

Financial Efficiency

Return on equity (ROE) is 103.30% and return on invested capital (ROIC) is 9.53%.

Return on Equity (ROE) 103.30%
Return on Assets (ROA) 7.30%
Return on Capital (ROIC) 9.53%
Revenue Per Employee $1.06M
Profits Per Employee $251,573
Employee Count 26,700
Asset Turnover 0.31
Inventory Turnover 1.17

Taxes

In the past 12 months, Amgen has paid $1.14 billion in taxes.

Income Tax 1.14B
Effective Tax Rate 14.49%

Stock Price Statistics

The stock price has increased by +19.22% in the last 52 weeks. The beta is 0.58, so Amgen's price volatility has been lower than the market average.

Beta (1Y) 0.58
52-Week Price Change +19.22%
50-Day Moving Average 290.10
200-Day Moving Average 268.32
Relative Strength Index (RSI) 55.59
Average Volume (30 Days) 3,032,721

Short Selling Information

The latest short interest is 11.11 million, so 2.07% of the outstanding shares have been sold short.

Short Interest 11.11M
Short Previous Month 11.02M
Short % of Shares Out 2.07%
Short % of Float 2.08%
Short Ratio (days to cover) 3.52

Income Statement

In the last 12 months, Amgen had revenue of $28.19 billion and earned $6.72 billion in profits. Earnings per share was $12.49.

Revenue 28.19B
Gross Profit 19.74B
Operating Income 7.90B
Pretax Income 7.86B
Net Income 6.72B
EBITDA 14.80B
EBIT 10.73B
Earnings Per Share (EPS) $12.49
Full Income Statement

Balance Sheet

The company has $10.94 billion in cash and $64.61 billion in debt, giving a net cash position of -$53.67 billion or -$100.14 per share.

Cash & Cash Equivalents 10.94B
Total Debt 64.61B
Net Cash -53.67B
Net Cash Per Share -$100.14
Equity / Book Value 6.23B
Book Value Per Share 11.63
Working Capital 11.94B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $8.47 billion and capital expenditures -$1.11 billion, giving a free cash flow of $7.36 billion.

Operating Cash Flow 8.47B
Capital Expenditures -1.11B
Free Cash Flow 7.36B
FCF Per Share $13.76
Full Cash Flow Statement

Margins

Gross margin is 70.02%, with operating and profit margins of 28.01% and 23.83%.

Gross Margin 70.02%
Operating Margin 28.01%
Pretax Margin 27.86%
Profit Margin 23.83%
EBITDA Margin 52.50%
EBIT Margin 38.06%
FCF Margin 26.11%

Dividends & Yields

This stock pays an annual dividend of $9.00, which amounts to a dividend yield of 3.17%.

Dividend Per Share $9.00
Dividend Yield 3.17%
Dividend Growth (YoY) 7.62%
Years of Dividend Growth 13
Payout Ratio 72.06%
Buyback Yield 0.55%
Shareholder Yield 3.70%
Earnings Yield 4.38%
FCF Yield 4.80%
Dividend Details

Analyst Forecast

The average price target for Amgen is $292.95, which is 3.04% higher than the current price. The consensus rating is "Buy".

Price Target $292.95
Price Target Difference 3.04%
Analyst Consensus Buy
Analyst Count 20
Revenue Growth Forecast (5Y) 4.39%
EPS Growth Forecast (5Y) 12.58%
Stock Forecasts

Stock Splits

The last stock split was on November 22, 1999. It was a forward split with a ratio of 2:1.

Last Split Date Nov 22, 1999
Split Type Forward
Split Ratio 2:1

Scores

Amgen has an Altman Z-Score of 1.43 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.43
Piotroski F-Score 6